ACAM2000
As of the edition of 20 October 2026, ACAM2000 is a drug known only by a code name: marketed, first approved in 2007 (US); US protection ended in 2019.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2007
- Kind
- Code name only
- Brand name
- Acam2000
- First approved
- 31 August 2007 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Emergent Product Development Gaithersburg, Inc.
- Registered trials
- 2, 0 stopped early
US protection
US protection ended in 2019.
US protection ended in 2019, computed as 12 years from the first US licence because FDA publishes no date for this product. The application that gives this date is held by Emergent Product Development Gaithersburg, Inc.. The date is computed, not published.
This is the US only, and it is not the date generics or biosimilars can enter.
The exact date and the listings behind it
In the product1 listing counts towards this date. The exact date and each listing are in the product.
See the exact date and the 1 listing behind itRequest access. Nothing is shown until you do.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 2 | 2 | 0 | 0 |
| All trials | 2 |